Radius Health, Inc.
Formerly MPM ACQUISITION CORP.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| May 2011 | $64 M | Issued in a merger or acquisition | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Radius Health, Inc. had no revenue when it filed its newest notice of a funding round (May 2011).
SEC Form D (revenue range) · May 2011
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · May 2011
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
25 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| BB Biotech AG | Company | not stated | not stated | Held Series A-1 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| F2 Bioscience GP Ltd. | Company | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| F2 Bioscience III, L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| F2 Bioscience IV GP Ltd. | Company | not stated | not stated | Held Series B-2 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| F2 Bioscience IV L.P. | Fund or asset manager | not stated | not stated | Held Series B-2 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| F2 Bio Ventures GP Ltd. | Venture capital | not stated | not stated | Held Series B-2 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| F2 Bio Ventures V L.P. | Venture capital | not stated | not stated | Held Series B-2 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| F2 Capital Ltd | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Globeways Holdings Ltd | Company | not stated | not stated | Held Series B-2 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| HealthCare Partners VII, L.P. | Fund or asset manager | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Healthcare Private Equity Limited Partnership | Private equity | not stated | not stated | Held Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2012) | SEC Form 3 |
| Healthcare Ventures VII LP | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Ipsen, S.A. | Company | not stated | not stated | Held Series A-1 preferred stock (Form 3, 2011) | SEC Form 3 |
| MPM Asset Management Investors 2003 Bviii LLC | Fund or asset manager | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bio IV NVS Strategic Fund LP | Fund or asset manager | not stated | not stated | Held Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM BIOVENTURES III GMBH & CO. Beteiligungs KG | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bioventures III GP L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bioventures III LLC | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bioventures III L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bioventures III Parallel Fund, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM Bioventures III-Qp L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2 and A-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM BioVentures IV GP LLC | Venture capital | not stated | not stated | Held Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| MPM BioVentures IV LLC | Venture capital | not stated | not stated | Held Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Nordic Bioscience Clinical Development VII A/S | Person | not stated | not stated | Held Series A-5 and A-6 preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | Fund or asset manager | not stated | not stated | Held Series A-1 and A-2 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| B. Nicholas Harvey | Mr. Harvey is a Senior Vice President, Chief Financial Officer, the Treasurer and Secretary of the Issuer. | May 2011 |
| C. Richard Lyttle | Dr. Lyttle is the President, Chief Executive Office and a Director of the Issuer. | May 2011 |
| Gary Nicholas Hattersley | Dr. Hattersley is a Vice President of the Issuer. | May 2011 |
| Louis Nicholas O'Dea | Dr. O'Dea is a Senior Vice President and the Chief Medical Officer of the Issuer. | May 2011 |
| Alan Nicholas Auerbach | Mr. Auerbach is a director of the Issuer. | May 2011 |
| Ansbert K. Gadicke | Dr. Ansbert is a director of the Issuer. | May 2011 |
| C. Richard Lyttle | Dr. Lyttle is the President, Chief Executive Office and a Director of the Issuer. | May 2011 |
| Elizabeth K. Stoner | Dr. Stoner is a director of the Issuer. | May 2011 |
| Jonathan Nicholas Fleming | Mr. Fleming is a director of the Issuer. | May 2011 |
| Kurt K. Graves | Mr. Graves is a director of the Issuer. | May 2011 |
| Martin K. Muenchbach | Dr. Muenchbach is a director of the Issuer. | May 2011 |
| Alan Nicholas Auerbach | Mr. Auerbach is a director of the Issuer. | May 2011 |
| Ansbert K. Gadicke | Dr. Ansbert is a director of the Issuer. | May 2011 |
| B. Nicholas Harvey | Mr. Harvey is a Senior Vice President, Chief Financial Officer, the Treasurer and Secretary of the Issuer. | May 2011 |
| C. Richard Lyttle | Dr. Lyttle is the President, Chief Executive Office and a Director of the Issuer. | May 2011 |
| Elizabeth K. Stoner | Dr. Stoner is a director of the Issuer. | May 2011 |
| Gary Nicholas Hattersley | Dr. Hattersley is a Vice President of the Issuer. | May 2011 |
| Kurt K. Graves | Mr. Graves is a director of the Issuer. | May 2011 |
| Louis Nicholas O'Dea | Dr. O'Dea is a Senior Vice President and the Chief Medical Officer of the Issuer. | May 2011 |
| Martin K. Muenchbach | Dr. Muenchbach is a director of the Issuer. | May 2011 |